Jump to content

HIV/AIDS in Algeria

From Wikipedia, the free encyclopedia
(Redirected from Draft:HIV/AIDS in Algeria)

Algeria has one of the lowest HIV/AIDS prevalence rates in Africa. In 2022, the United Nations estimated that there were 10,000 adults and children living with the disease in the country, accounting for 0.05% of the total population.https://www.unaids.org/en/regionscountries/countries/algeria

Prevalence

[edit]

HIV/AIDS was first identified in Sétif in 1986. Around 5000 Algerians have died of AIDS-related complications since the epidemic began.[1][2]

During the early years of the epidemic, national understanding of the disease was low, which led to a likely discrepancy in the number of Algerians contracting HIV/AIDS with the number of reported cases. The traditionally conservative culture often meant that discussing the disease, either publicly or privately, was considered a social taboo.[3]

The World Health Organization has identified drug users, sex workers and men who have sex with men as being the key populations among whom the HIV/AIDS epidemic is concentrated.[4]

The number of women infected with HIV/AIDS has sharply increased, with the ratio of men to women having contracted the disease changing from 5:1 at the beginning of the epidemic to 1:1 by 2004. This has been attributed to the prevalence of married Algerian men having extra-marital affairs, contracting HIV/AIDS and subsequently transmitting it to their wives.[5]

Subtype B is the most common type of HIV in northern Algeria, accounting for 56% of cases. There is more variety of strains in southern Algeria, which has been linked to its closer proximity with sub-Saharan countries where HIV/AIDS is more prevalent.[5]

National response

[edit]

On 1 December 2003, then-President of Algeria Abdelaziz Bouteflika made a speech commemorating World AIDS Day, marking the first time he had extensively discussed HIV/AIDS. He stressed the importance of breaking the cultural taboo around discussing the disease, in addition to raising public awareness about HIV/AIDS, its transmission, symptoms, testing, and treatment; addressing women's social vulnerability to contacting the disease; the importance of maintaining confidentiality within the health service; and addressing the disease in a culturally appropriate way.[6]

The Algerian government's subsequent response to the HIV/AIDS epidemic has been praised by the Joint United Nations Programme on HIV/AIDS, which described the country as a "pioneer in the region" for its prioritisation of cross-sectoral action, community involvement, and innovative policies, which it said had led to a sustained low-level epidemic.[7][8] Universal health care is enshrined in the Constitution of Algeria, and free antiviral therapy has been offered to patients since 1998.[6][9]

In 2012, Algeria partnered with UNAIDS to build the first HIV/AIDS research centre in the Middle East and North Africa, to be based in Tamanrasset, close to the country's borders with several countries and on a popular route for migrants.[10] As of 2016, all health centres in Algeria have HIV/AIDS testing facilities, with the Algiers Centre of Excellence for Research on Health and HIV/AIDS serving as a regional hub for research, training, and medicine production pertaining to HIV/AIDS.[9]

In 2016, the Algiers Declaration was signed, vowing to eradicate HIV/AIDS in North Africa and the Middle East by promoting increased testing and treatment, particularly among drug users, sex workers, and men who have sex with men.[9]

The role of non-governmental organisations such as Solidarité AIDS and El-Hayat have been attributed to Algeria's response to the epidemic.[7] This has included completing outreach work with vulnerable groups, such as offering condoms and testing to licensed sex workers.[5][6]

Difficulties in treatment

[edit]

While the overall prevalence of HIV/AIDS is low in Algeria, public understanding of the disease and how it is transmitted has been described as "mediocre" among the population, particularly among young people.[2][4] While it is taught as part of secondary education, access to HIV/AIDS services like testing, treatment and advice is only available to people under 18 with parental consent.[4] The stigmatisation of people with HIV/AIDS has led to some parents not consenting, as well as to adults with the disease declining testing or antiretroviral drugs.[10]

References

[edit]
  1. ^ Ouyahia, Amel; Rais, Mounira; Gasmi, Abdelkader; Guenifi, Wahiba; Mechakra, Salah; Lacheheb, Abdemadjid (11 May 2023). "HIV/AIDS epidemic features and trends in Setif city (Algeria) from 1986 to 2009". Retrovirology. 7. doi:10.1186/1742-4690-7-S1-P99. PMC 3315915.
  2. ^ a b Zhang, Yawei (2008). Encyclopedia of Global Health. Vol. 1. Thousand Oaks: SAGE Publications. ISBN 9781412941860.
  3. ^ Hadefri, R. (March 1995). "AIDS in Algeria: the disease and the shame". AIDS Analysis Africa. 5 (2): 5. PMID 12288605 – via National Library of Medicine.
  4. ^ a b c "HIV/AIDS Infographics - Algeria country profile". UNPFA. July 2021. Retrieved 13 August 2023.
  5. ^ a b c Abu-Raddad, Laith J.; Ayodeji-Akala, Francisca; Semini, Iris; Riedner, Gabriele; Wilson, David; Tawil, Ousama (2010). Characterising the HIV/AIDS Epidemic in the Middle East and North Africa: Time for Strategic Action. Washington, D.C.: World Bank. ISBN 9780821381380.
  6. ^ a b c Ayodeji-Akala, Francisca; Jenkins, Carolyn (2005). Preventing HIV/AIDS in the Middle East and North Africa: A Window of Opportunity to Act. Washington, D.C.: World Bank. ISBN 978-0-8213-6264-8.
  7. ^ a b Jones, Kalli (2021). "Prevalence of the HIV/AIDS Epidemic in Algeria" (PDF). Mercer University's Department of International and Global Studies. Retrieved 13 August 2023.
  8. ^ "Youth and innovation shine on World AIDS Day in Algeria". UNAIDS. 1 December 2016. Retrieved 13 August 2023.
  9. ^ a b c "Algeria leads push to end the AIDS epidemic in the Middle East and North Africa". UNAIDS. 15 January 2016. Retrieved 13 August 2023.
  10. ^ a b Boumedjout, Hichem (10 May 2012). "Algeria to tackle HIV/AIDS". Nature – via doi.org.